TRIB3 and pulmonary arterial hypertension: Attenuating ERS with 4-PBA was proved as a novel therapeutic strategy in pulmonary hypertension [6], TRB3 maybe a potent target of ERS inhibitors in decreasing pulmonary artery remodeling.